Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.
Hepato-Biliary and Liver Transplant Unit, Hôpital Paul Brousse, Villejuif, France.
F
F
Saliba
D
D
Eyraud
D
D
Samuel
M F
MF
David
J L
JL
Arulnaden
E
E
Dussaix
D
D
Mathieu
H
H
Bismuth
D000212:Acyclovir / Q000627:therapeutic use*; D000328:Adult; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000502:physiology; D008297:Male; D008875:Middle Aged
D007166:Immunosuppressive Agents; D000212:Acyclovir